JWCA has advised rhythm pharmaceuticals on capital market transactions with $900 BILLION in transaction Value

November 2026: JWCA advises Rhythm Pharmaceuticals on its $750 term loan facility

April 2024: JWCA advises Rhythm Pharmaceuticals on its $150 million convertible preferred stock issuance led by Perceptive Advisors